tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market
MNPR
Monopar Therapeutics Inc
RESEARCH TOOLSreports
Want to see MNPR full AI Analyst Report?

Monopar Therapeutics Inc (MNPR) Stock News & Sentiment

574 Followers
Monopar Showcases ALXN1840 Phase 2 Wilson Disease Data
Premium
Company Announcements
Monopar Showcases ALXN1840 Phase 2 Wilson Disease Data
3d ago
8K
MNPR
Monopar Buy Rating Reiterated on Advancing ALXN1840 Profile and De-Risked Regulatory Path; $104 Price Target Unchanged
Premium
Ratings
Monopar Buy Rating Reiterated on Advancing ALXN1840 Profile and De-Risked Regulatory Path; $104 Price Target Unchanged
7d ago
MNPR
Monopar Highlights Strong Phase 3 Data for ALXN1840
Premium
Company Announcements
Monopar Highlights Strong Phase 3 Data for ALXN1840
1M ago
8K
MNPR
ALXN1840 Poised to Redefine Wilson Disease Treatment Standards: Phase 3 Success, De-Risked Profile, and Buy Rating Justification
Premium
Ratings
ALXN1840 Poised to Redefine Wilson Disease Treatment Standards: Phase 3 Success, De-Risked Profile, and Buy Rating Justification
1M ago
MNPR
Buy Rating Reaffirmed on ALXN1840 De‑Risking, 2027 Approval Potential, and Strong Cash Runway
Premium
Ratings
Buy Rating Reaffirmed on ALXN1840 De‑Risking, 2027 Approval Potential, and Strong Cash Runway
2M ago
MNPR
MNPR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MNPR Upcoming Earnings Report: What to Expect?
2M ago
MNPR
Monopar Appoints Chief Commercial and Strategy Officer Rodriguez
Premium
Company Announcements
Monopar Appoints Chief Commercial and Strategy Officer Rodriguez
3M ago
8K
MNPR
More MNPR News >

MNPR News on the Web

Monopar Showcases ALXN1840 Phase 2 Wilson Disease Data
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), Voyager Therapeutics (VYGR)
TipRanks News
Bullish
Morgan Stanley Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Elutia (ELUT), Monopar Therapeutics Inc (MNPR)
TipRanks News
Bullish
Leerink Partners Sticks to Its Buy Rating for Monopar Therapeutics Inc (MNPR)
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Monopar Therapeutics Inc (MNPR), First Tracks Biotherapeutics Inc (TRAX)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Monopar Buy Rating Reiterated on Advancing ALXN1840 Profile and De-Risked Regulatory Path; $104 Price Target Unchanged
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MNPR
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.25 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNPR’s Media Buzz Sentiment?
4 articles about MNPR were published this week. In an average week, 3.25 articles are published.
    What is MNPR’s weekly average amount of articles?
    In an average week, 3.25 articles about MNPR are published.
      What is MNPR’s News Sentiment?
      99% of articles about MNPR were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        JUNSJupiter Neurosciences, Inc.
        Showing the stocks with the most bullish news sentiment over the past week